From Philips Medical Systems;
the Intera 3 T high field system, the first with a compact magnet, which is built on the same platform as the 1.5 T, is targeted to high-end neurological, orthopedic and cardiovascular imaging applications with maximum patient comfort and acceptance without compromising image quality and clinical performance. Useable for clinical routine and research. The Intera systems offer diffusion tensor imaging (DTI) fiber tracking that measures movement of water in the brain and can therefore detect areas of the brain where normal movement of water is disrupted.

From Philips Medical Systems;
The clinical capabilities of MR will further expand. Inside and out, the Achieva is a friendly, open system designed for optimal patient comfort and maximized workflow with high functionality. The Achieva 1.5T can be upgraded to Achieva I/T, with three configurations optimized for MR guided interventions and therapy:

From Philips Medical Systems;
Philips continues to expand the frontiers of utra high field MRI with the introduction of the new Intera Achieva 3.0T™. Its powerful future-safe platform shares all the advantages of the Achieva family and covers applications throughout the whole body.

From Philips Medical Systems;
The Intera Achieva CV is focused on cardiovascular imaging research and development, generating technology on the cutting edge for modern clinical needs, like easy coronary artery imaging, the evaluation of flow effects in vessels and peripheral angiography with optimal resolution per station.

The owner of MRI equipment has to ensure that the equipment does fulfill the local requirements.
In some countries, the requirements are more stringent than in others; in other countries, they are nonexistent.
The user in general is unable to check power output, gradient strength, or even field strength. The manufacturer has to cover authorized hardware and software updates after the initial installation and has to give guarantee for the requirements. Specially designed computer programs usually supervise the power output of MRI devices and will not allow or will interrupt any imaging or spectroscopy procedure exceeding those limits considered safe.

See also European Medicines Agency, FDA information:
www.fda.gov/cdrh/safety/mrisafety.html